08 혈당 조절 목표 113

## 권고 사항

1.  혈당 조절 목표치는 연령, 당뇨병 유병 기간, 중증 저혈당 위험, 심혈관 질환 유무, 예상 수명에 따라 개별화한다 [D 등급, 합의].
2.  미세혈관 합병증 위험 감소를 위해 당화혈색소 7.0% 이하를 목표로 하고 [A 등급, 근거 수준 1A], 대혈관 합병증 위험 감소를 위해 당뇨병 진단단계부터 치료를 시작한다 [B 등급, 근거 수준 3].
3.  2형 당뇨병 환자에서 신병증 위험 [A 등급, 근거 수준 1]을 낮추기 위해 6.5% 이하의 당화혈색소를 목표로 할 수 있으나 [A 등급, 근거 수준 1], 저혈당에 주의한다 [A 등급, 근거 수준 1].
4.  다음 환자에서는 느슨한 당화혈색소 목표(대부분 7.1-8.5%)를 고려한다.
    a) 제한된 수명
    b) 심한 활동능력 장애
    c) 허혈성 심장 질환 고위험군
    d) 다수의 동반질환
    e) 빈번하고 심한 저혈당
    f) 저혈당 인지 장애
    g) 유병 기간이 길어 강화 치료에도 불구하고 혈당 조절이 불량한 당뇨병 환자

## 참고 문헌

1.  UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
2.  The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995;44:968-83.
3.  Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes(UKPDS 35):prospective observational study. BMJ 2000;321:405-12.
4.  Service FJ, O’Brien PC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia 2001;44:1215-20.
5.  Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40.
6.  Levitan EB, Song Y, Ford ES, et al. Is nondiabetic hyperglycemia a risk factor forcardiovascular disease? Arch Intern Med 2004;164:2147-55.
7.  DECODE Study Group, European Diabetes Epidemiology Group. Is current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular causes? Diabetes Care 2003;26:688-96.
8.  Sorkin JD, Muller DC, Fleg JL, et al. The relation of fasting and 2-h postchallenge plasma glucose to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 2005;28:2626-32.
9.  Cavalot F, Pagliarino A, Valle M, et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year-follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care 2011;34:2237-43.
<PAGE>113